Institute News
Most Popular
Positive Phase 3 Topline Results Announced for NT-501 Implant in MacTel
November 2, 2022 Neurotech Pharmaceuticals, Inc. announces positive Phase 3 topline results for NT-501 implant in macular telangiectaisa type 2 (MacTel). (Cumberland, RI) Clinically relevant and statistically significant primary results with t...
MacTel SAFE Study
March 6, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database. LMRI is conducting the SAFE study (Phase 2a Study of the Effect of Serine Supplementation and Fenofibrate Treatment on Serum...
MacTel Project 2021 Update
LOWY MEDICAL RESEARCH INSTITUTE - LMRI This past year has surely been an interesting and challenging one. We hope that you and your family, friends, neighbors, and coworkers were able to weather the events safely. Despite the many challenges prese...
Free community webinar about MacTel
November 14, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database. Neurotech has partnered with Prevent Blindness to sponsor an online event with a focus on MacTel Type 2. This free webinar...